Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment

BACKGROUND: Primary tumor location (PTL) is an important prognostic and predictive factor in the first-line treatment of metastatic colorectal cancer (mCRC). Although regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) have been introduced recently, the clinical impact of PTL in these treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Hiromichi, Fukuoka, Shota, Masuishi, Toshiki, Takashima, Atsuo, Kumekawa, Yosuke, Kajiwara, Takeshi, Yamazaki, Kentaro, Negoro, Yuji, Komoda, Masato, Makiyama, Akitaka, Denda, Tadamichi, Hatachi, Yukimasa, Suto, Takeshi, Sugimoto, Naotoshi, Enomoto, Masanobu, Ishikawa, Toshiaki, Kashiwada, Tomomi, Ando, Koji, Yuki, Satoshi, Okuyama, Hiroyuki, Kusaba, Hitoshi, Sakai, Daisuke, Okamoto, Koichi, Tamura, Takao, Yamashita, Kimihiro, Gosho, Masahiko, Moriwaki, Toshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239287/
https://www.ncbi.nlm.nih.gov/pubmed/34211856
http://dx.doi.org/10.3389/fonc.2021.688709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239287/
https://www.ncbi.nlm.nih.gov/pubmed/34211856
http://dx.doi.org/10.3389/fonc.2021.688709

Ejemplares similares